Keynote Speaker:
The Honorable Mike Rogers, Congressman (R-MI)

Featured Speakers:
Anne Schuchat, M.D.,Rear Admiral, United States Public Health Service; Assistant Surgeon General; Director, National Center for Immunization and Respiratory Diseases (proposed), Centers For Disease Control And Prevention (CDC)

Franz Kracher, Ph.D., Project Officer, Unit SANCO C3 – Health Threats, DG Health and Consumer Protection, Director C Public Health and Risk Assessment, European Commission

James Young, Ph.D., President, Research & Development, MedImmune, Inc.

And Senior Representatives from:
Government Agencies

Steven A. Adams, MPH, Director (acting), Division of Strategic National Stockpile (SNS) , Centers for Disease Control and Prevention (CDC)

Erik A. Henchal, Ph.D., FAAMM, Associate Director, Office of Vaccines Research and Review, Center for Biologics Evaluation and Research (CBER), U.S. Food and Drug Administration (FDA)

Robin Robinson Ph.D., Acting Associate Director for Influenza Programs, Office of Research and Development Coordination, Office of Public Health Emergency Preparedness, Department Of Health & Human Services (DHHS)

Biopharmaceutical Companies
Kim C. Bush, President, Baxter Vaccines

James Matthews, Ph.D., Senior Director, Health and Science Policy, Sanofi Pasteur SA

Mike McGuire, Vice President, Anti-Infectives Marketing, Roche

Garry Redlich, Managing Director, Implicit Bioscience Pty Ltd.

Sarah R. Landry, Director of Public Policy-Vaccines, GlaxoSmithKline.

Hal Siegel, Ph.D. Senior Director of Development and Regulatory Affairs, ImmuneRegen BioSciences, Inc.

Rahul Singhvi, Ph.D., President and CEO, Novavax Inc.

Friso van Voorthuizen, Ph.D., Global Director Pandemic Preparedness & Manufacturing Liaison, Solvay Pharmaceuticals B.V.

Medicine and Supply Distributors
Claude Grant, Senior Vice President, Quality and Regulatory Affair, Cardinal Health

Chris Ground, Senior Vice President, National Accounts, FFF Enterprises, Inc.

Neil Herson, President, ASD Healthcare

Others Key Advisors:
Bill Helming, Vice President, Biodefense and Public Health Practice, PRTM Management Consultants

John A. Muckstadt, Acheson/Laibe Professor of Business Management and Leadership Studies, School of Operations Research and Industrial Engineering, Cornell University

Frank M. Rapoport, Partner, McKenna Long & Aldridge LLP

Sharon Seiler, Ph.D., Vice President – Senior Biotechnology Analyst, Punk, Ziegel & Company